Fundz

Eleven Biotherapeutics, Inc. reported raising $13.5 Million in an initial SEC Form D filing, from an offering of $13.5 Million

TAKEN PRIVATESep 28, 2016

Amount Raised

$13.5 Million

$13.5 Million sold, per SEC Form D (first sale Sep 28, 2016)

Round Type

Venture

CambridgeBiotechnology

Quick answer

Eleven Biotherapeutics, Inc. raised $13.5 Million in a funding round, dated September 28, 2016. Eleven Biotherapeutics, Inc. is based in Cambridge, Massachusetts, United States.

How much did Eleven Biotherapeutics, Inc. raise?
Eleven Biotherapeutics, Inc. raised $13.5 Million in a funding round on September 28, 2016.
What does Eleven Biotherapeutics, Inc. do?
Eleven Biotherapeutics is focused on developing innovative protein-based therapeutics to improve human health and treat diseases.
Where is Eleven Biotherapeutics, Inc. based and how big is it?
Eleven Biotherapeutics, Inc. is based in Cambridge, Massachusetts, United States.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Eleven Biotherapeutics, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Arq raised $22M on November 4, 2016.
  • TuHURA Biosciences raised an undisclosed amount on November 4, 2016.
  • Skye Bioscience raised $500K (Seed) on November 4, 2016.
  • InnAVasc Medical, Inc. raised $2.1M (Seed) on November 4, 2016.
  • Crispr Therapeutics raised $35M on November 4, 2016.
  • Amyris raised $6M on November 4, 2016.

Who to call at Eleven Biotherapeutics, Inc., and when

A new round usually means Eleven Biotherapeutics, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Eleven Biotherapeutics, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Eleven Biotherapeutics, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Eleven Biotherapeutics, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Eleven Biotherapeutics, Inc.

Location

215 FIRST STREET

Cambridge, Massachusetts, United States

About

Eleven Biotherapeutics is focused on developing innovative protein-based therapeutics to improve human health and treat diseases.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Eleven Biotherapeutics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Eleven Biotherapeutics, Inc.'s next move

See what Strategic adds

Eleven Biotherapeutics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.